EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy of the Phosphorothioate Antisense Oligonucleotide Regenera-11 in Prednisolone-Induced Gastric Mucosal Injury in Wistar Rats

Alyona A. Yurchenko, Tatyana P. Makalish, Kseniya A. Yurchenko, Kirill V. Pokidchenko, Igor V. Cheretaev, Anatolii V. Kubyshkin, Vladimir V. Oberemok

Sci · 16.11.2026 · 8 (11) · 373

DOI: 10.3390/sci8110373 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Sci, online erschienen am 16.11.2026. Verfasst von Alyona A. Yurchenko und 6 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: V.I. Vernadsky Crimean Federal University.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antisense technologies represent a promising approach in the development of therapeutic strategies for a wide range of diseases. Advances in the understanding of disease pathogenesis and molecular mechanisms underlying gastric mucosal injury, as well as the associated signaling pathways, have enabled the identification of multiple targets for phosphorothioate antisense oligonucleotides (ASOs). In this study, we evaluated cyclooxygenase-2 (COX-2) gene expression, histological and morphological changes in the gastric tissue of Wistar rats, as well as hematological parameters and systemic physiological indicators. Phosphorothioate ASOs exhibit high sequence specificity, binding to target mRNA and inducing its degradation, thereby reducing the expression of the corresponding protein. For the first time, we report an analysis of the effects of the phosphorothioate antisense oligonucleotide Regenera-11 and its modified variants (Regenera-5′ and Regenera-3′) in a prednisolone-induced gastric mucosal injury model in Wistar rats. Suppression of COX-2 expression was associated with enhanced mucosal repair and a reduction in the severity of histological damage. These findings suggest that Regenera-11 may represent a promising candidate for further preclinical investigation and the development of targeted therapeutic strategies.

Förderung

  • V.I. Vernadsky Crimean Federal University

Zitieren

APA

Yurchenko, A. A., Makalish, T. P., Yurchenko, K. A., Pokidchenko, K. V., Cheretaev, I. V., Kubyshkin, A. V., & Oberemok, V. V. (2026). Efficacy of the Phosphorothioate Antisense Oligonucleotide Regenera-11 in Prednisolone-Induced Gastric Mucosal Injury in Wistar Rats. Sci, 8(11), 373. https://doi.org/10.3390/sci8110373

Vancouver

Yurchenko AA, Makalish TP, Yurchenko KA, Pokidchenko KV, Cheretaev IV, Kubyshkin AV, et al. Efficacy of the Phosphorothioate Antisense Oligonucleotide Regenera-11 in Prednisolone-Induced Gastric Mucosal Injury in Wistar Rats. Sci. 2026;8(11):373. doi:10.3390/sci8110373

BibTeX
@article{Yurchenko2026,
  author = {Yurchenko, Alyona A. and Makalish, Tatyana P. and Yurchenko, Kseniya A. and Pokidchenko, Kirill V. and Cheretaev, Igor V. and Kubyshkin, Anatolii V. and Oberemok, Vladimir V.},
  title = {Efficacy of the Phosphorothioate Antisense Oligonucleotide Regenera-11 in Prednisolone-Induced Gastric Mucosal Injury in Wistar Rats},
  journal = {Sci},
  year = {2026},
  volume = {8},
  number = {11},
  pages = {373},
  doi = {10.3390/sci8110373}
}
Kostenlos starten →